Embla Medical hf. (CPH:EMBLA)

Embla Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	76.01	102.51	86.16	72.65	76.63	85.2
Cash & Short-Term Investments	76.01	102.51	86.16	72.65	76.63	85.2
Cash Growth	-25.54%	18.97%	18.59%	-5.19%	-10.05%	-16.77%
Accounts Receivable	149.47	144.78	121.92	127.84	112.37	102.77
Other Receivables	-	8.76	7.36	5.52	4.36	2.76
Receivables	149.47	153.54	129.28	133.37	116.74	105.52
Inventory	165.55	165.62	143.1	136.23	132.13	103.99
Prepaid Expenses	-	19.28	22.63	17.66	14.5	14.05
Other Current Assets	59.41	17.06	15.78	16.07	8.86	9.48
Total Current Assets	450.43	458	396.96	375.98	348.85	318.23
Property, Plant & Equipment	230.62	242.73	199.63	186.06	179.32	182.08
Long-Term Investments	34.67	29.6	21.22	23.44	17.08	13.65
Goodwill	823.87	835.56	776.31	690.86	680.4	644.15
Other Intangible Assets	99.95	106.91	96.65	65.84	62	58.84
Long-Term Deferred Tax Assets	53.08	55.38	46.37	41.89	37.32	27.04
Other Long-Term Assets	3.91	2.32	1.85	1.63	0.39	2.92
Total Assets	1,697	1,730	1,539	1,386	1,325	1,247

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	33.04	32.83	27.28	30.75	28.65	26.72
Accrued Expenses	54.71	91.52	76.73	78.86	63.35	62.49
Current Portion of Long-Term Debt	136.41	67.68	28.62	21.53	62.07	46.04
Current Portion of Leases	27.31	28.22	24.14	21.79	24.77	21.24
Current Income Taxes Payable	19.19	21.32	18.31	12.14	11.01	7.35
Current Unearned Revenue	-	3.01	2.72	2.84	3.32	3.37
Other Current Liabilities	81.25	65	31.5	28.28	43.84	19.24
Total Current Liabilities	351.92	309.57	209.28	196.2	237.01	186.46
Long-Term Debt	181.59	292.17	328.75	311.8	277.71	262.19
Long-Term Leases	145.14	153.5	118.28	112.61	116.38	118.67
Long-Term Unearned Revenue	11.24	11.35	8.59	7.28	6.04	6.25
Long-Term Deferred Tax Liabilities	38.53	39.79	37.48	28.78	29.6	29.03
Other Long-Term Liabilities	17.84	28.31	55.88	24.02	23.12	17.72
Total Liabilities	746.25	834.69	758.27	680.68	689.85	620.32

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.82	4.84	4.83	4.78	4.78	4.8
Additional Paid-In Capital	82.75	93.63	88.64	61.48	61.43	70.78
Retained Earnings	913.06	843.84	760.38	700.93	641.23	593.2
Comprehensive Income & Other	-55.45	-51.76	-76.66	-65.31	-71.74	-47.18
Total Common Equity	945.17	890.55	777.19	701.88	635.7	621.59
Minority Interest	5.12	5.25	3.51	3.12	-0.19	5.01
Shareholders' Equity	950.29	895.8	780.7	705.01	635.51	626.6
Total Liabilities & Equity	1,697	1,730	1,539	1,386	1,325	1,247

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	490.45	541.57	499.79	467.73	480.92	448.15
Net Cash (Debt)	-414.45	-439.06	-413.63	-395.08	-404.29	-362.95
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.97	-1.03	-0.97	-0.94	-0.97	-0.86
Filing Date Shares Outstanding	425.25	427.77	427.3	420.3	420.29	422.26
Total Common Shares Outstanding	425.25	427.77	426.93	420.3	420.29	422.26
Working Capital	98.52	148.43	187.67	179.78	111.84	131.78
Book Value Per Share	2.22	2.08	1.82	1.67	1.51	1.47
Tangible Book Value	21.36	-51.92	-95.77	-54.81	-106.7	-81.4
Tangible Book Value Per Share	0.05	-0.12	-0.22	-0.13	-0.25	-0.19
Buildings	-	-	-	-	2.26	1.61
Machinery	133.27	125.86	109	101.68	129.71	135.77
Leasehold Improvements	65.08	62.75	51.27	42.81	-	-

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error